Mr. Horsman et al., EFFECT OF NITRO-L-ARGININE ON BLOOD-FLOW, OXYGENATION AND THE ACTIVITY OF HYPOXIC CELL CYTOTOXINS IN MURINE TUMORS, British Journal of Cancer, 74, 1996, pp. 168-171
This study was an investigation into the ability of nitro-L-arginine t
o change blood flow, oxygenation status and the activity of hypoxic ce
ll cytotoxic agents in two different transplanted murine tumours. The
tumour models were the C3H mammary carcinoma grown in the feet of fema
le CDF1 mice and the SaF grown on the backs of CBA mice. Treatments we
re carried out in restrained non-anaesthetised animals when tumours we
re about 100 to 200 mm(3) in size. Blood flow was monitored using lase
r Doppler flowmetry; oxygen partial pressure (pO(2)) distributions wer
e obtained with an Eppendorf oxygen electrode; and response to treatme
nt with hyperthermia (43.5 degrees C; 30 min) and RB6145 (250 mg kg(-1
); i.p.) assessed using a tumour growth delay assay. Nitro-L-arginine
(10 mg kg(-1); i.v.) significantly reduced blood flow by around 40-60%
within 15 min after injection in the C3H tumour and by 30 min in the
SaF. However, nitro-L-arginine had absolutely no effect on tumour pO(2
) measured at the time of maximal blood flow reduction in both tumour
types. It also failed to enhance the response of the C3H tumour to hea
t, but did produce a small yet significant increase in the response of
the SaF tumour to RB6145.